Pfizer Income from Continuous Operations 2010-2024 | PFE

Pfizer income from continuous operations for the twelve months ending December 31, 2024 was $8.051B, a 270.67% increase year-over-year.

  • Pfizer annual income from continuous operations for 2024 was $8.051B, a 270.67% increase from 2023.
  • Pfizer annual income from continuous operations for 2023 was $2.172B, a 93.08% decline from 2022.
  • Pfizer annual income from continuous operations for 2022 was $31.401B, a 39.81% increase from 2021.

Pfizer Income from Continuous Operations 2010-2024 | PFE

  • Pfizer annual income from continuous operations for 2024 was $8.051B, a 270.67% increase from 2023.
  • Pfizer annual income from continuous operations for 2023 was $2.172B, a 93.08% decline from 2022.
  • Pfizer annual income from continuous operations for 2022 was $31.401B, a 39.81% increase from 2021.
Related Stocks
Company NameMarket
Cap
Eli Lilly (LLY)$823.1B
Johnson & Johnson (JNJ)$380.1B
Novo Nordisk (NVO)$374.3B
AbbVie (ABBV)$348.4B
Roche Holding AG (RHHBY)$259.5B
Novartis AG (NVS)$218.5B
Merck (MRK)$216.5B
Sanofi (SNY)$136B
Bayer (BAYRY)$22B
Innoviva (INVA)$1.1B